NEUROMYELITIS OPTICS THERAPY MARKET ANALYSIS

Neuromyelitis Optics Therapy Market, by Drug Class (Corticosteroids, Immunosuppressive Agents (Azathioprine, Mycophenolate Mofetil, Rituximab, Eculizumab), and Others), by Distribution Channel (Online Retail Pharmacies and Offline Retail Pharmacies), and by Region (North America, Latin America, Europe, Middle East, Asia Pacific, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI4148
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Neuromyelitis Optica Therapy Market Key Players

Key players operating in the global neuromyelitis optica therapy market include Alexion Pharmaceuticals Inc., Chugai Pharmaceutical Co., Ltd., Viela Bio, Inc, Hansoh Pharmaceutical Group Company Limited, AstraZeneca plc, F. Hoffmann-La Roche AG, Zydus Pharmaceuticals (USA) Inc., Alkem Laboratories, Hikma Pharmaceuticals USA Inc., and Sandoz Inc.